Cargando…

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies

Objectives. To assess CCL18 and OX40L as biomarkers of interstitial lung disease (ILD) and/or progressive fibrosing (PF-) ILD in idiopathic inflammatory myopathies (IIMs). Methods. Patients with IIMs seen in our center from July 2020 to March 2021 were consecutively enrolled. ILD was detected by hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanatta, Elisabetta, Martini, Andrea, Depascale, Roberto, Gamba, Anna, Tonello, Marta, Gatto, Mariele, Giraudo, Chiara, Balestro, Elisabetta, Doria, Andrea, Iaccarino, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217155/ https://www.ncbi.nlm.nih.gov/pubmed/37238199 http://dx.doi.org/10.3390/diagnostics13101715

Ejemplares similares

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
por: Westerink, Lotte, et al.
Publicado: (2022)

Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype
por: Nili, Mona, et al.
Publicado: (2022)

Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
por: De Sadeleer, Laurens J., et al.
Publicado: (2020)

CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline
por: Balestro, Elisabetta, et al.
Publicado: (2020)

Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016)

ChILD – Children's interstitial lung disease
Publicado: (2018)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study
por: Joung, Kyung-In, et al.
Publicado: (2023)

The PH‐ILD Detection tool: External validation and use in patients with ILD
por: Parikh, Raj, et al.
Publicado: (2023)

Tracking Validation of ILD
por: Lu, S.
Publicado: (2018)

ILD simulation model
por: Lu, S.
Publicado: (2018)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
por: Fujii, Hiroaki, et al.
Publicado: (2023)

Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies
por: Ghirardello, Anna, et al.
Publicado: (2023)

The design of the ILD forward region
por: Levy, A
Publicado: (2018)

(Selected) MDI Issues of ILD
por: Pöschl, Roman
Publicado: (2020)

ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
por: Durheim, Michael T, et al.
Publicado: (2020)

Surfactant Metabolism Dysfunction and Childhood Interstitial Lung Disease (chILD)
por: McFetridge, Lynne, et al.
Publicado: (2009)

Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry
por: Behr, Juergen, et al.
Publicado: (2023)

An Unusual Association of Idiopathic Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) With Interstitial Lung Disease (ILD)
por: Saha, Shubhashis, et al.
Publicado: (2023)

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management
por: De Zorzi, Elena, et al.
Publicado: (2022)

Calibration of the Scintillator Hadron Calorimeter of ILD
por: CALICE Collaboration
Publicado: (2009)

Front-end Electronics for the TPC in ILD
por: Hedberg, V, et al.
Publicado: (2015)

Navigational Bronchoscopy with Cryobiopsy for Diagnosis of ILD
por: Figueroa Rodriguez, Fernando, et al.
Publicado: (2022)

Moving from PF-ILD to PPF
por: Bhattacharyya, Parthasarathi
Publicado: (2023)

ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs)
por: Mishra, Smriti, et al.
Publicado: (2018)

Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians
por: Althobiani, Malik, et al.
Publicado: (2021)

Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
por: Enomoto, Noriyuki, et al.
Publicado: (2022)

Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD
por: Furukawa, Hiroshi, et al.
Publicado: (2015)

Drugs in induction and treatment of idiopathic inflammatory myopathies
por: Iaccarino, Luca, et al.
Publicado: (2014)

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
por: Flaherty, Kevin R, et al.
Publicado: (2017)

Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model
por: Cao, Heng, et al.
Publicado: (2020)

An unusual case of interstitial lung disease: Revisiting peribronchiolar metaplasia interstitial lung disease (PBM‐ILD)
por: Jung, Flora, et al.
Publicado: (2023)

Laying the ground for research of interstitial lung disease in our country: ILD India registry
por: Singh, Virendra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_50gug71faoqch7hmfk8u9qptng